ATE306936T1 - Faenger fuer oxidantien - Google Patents
Faenger fuer oxidantienInfo
- Publication number
- ATE306936T1 ATE306936T1 AT96923328T AT96923328T ATE306936T1 AT E306936 T1 ATE306936 T1 AT E306936T1 AT 96923328 T AT96923328 T AT 96923328T AT 96923328 T AT96923328 T AT 96923328T AT E306936 T1 ATE306936 T1 AT E306936T1
- Authority
- AT
- Austria
- Prior art keywords
- oxidants
- catcher
- relates
- modulating
- processes
- Prior art date
Links
- 239000007800 oxidant agent Substances 0.000 title abstract 3
- 208000037273 Pathologic Processes Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000009054 pathological process Effects 0.000 abstract 1
- 230000035790 physiological processes and functions Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
- A61K47/546—Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/476,866 US5994339A (en) | 1993-10-15 | 1995-06-07 | Oxidant scavengers |
| US61341896A | 1996-03-11 | 1996-03-11 | |
| PCT/US1996/010497 WO1996040223A1 (en) | 1995-06-07 | 1996-06-07 | Oxidant scavengers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE306936T1 true ATE306936T1 (de) | 2005-11-15 |
Family
ID=27045322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96923328T ATE306936T1 (de) | 1995-06-07 | 1996-06-07 | Faenger fuer oxidantien |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0831891B1 (de) |
| JP (1) | JPH11509180A (de) |
| AT (1) | ATE306936T1 (de) |
| AU (1) | AU725602B2 (de) |
| CA (1) | CA2223407C (de) |
| DE (1) | DE69635304T2 (de) |
| ES (1) | ES2249784T3 (de) |
| IL (1) | IL122451A0 (de) |
| WO (1) | WO1996040223A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6127356A (en) | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
| US5834457A (en) * | 1996-01-26 | 1998-11-10 | The Regents Of The University Of California | Method of modulating radical formation by mutant cuznsod enzymes |
| JP2001521939A (ja) * | 1997-11-03 | 2001-11-13 | デューク・ユニバーシティー | 置換されたポルフィリン類 |
| DE69928655T2 (de) | 1998-04-24 | 2006-08-24 | Duke University | Substituierte porphyrine |
| WO2000009111A2 (en) * | 1998-08-11 | 2000-02-24 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Inhibitors of amyloid formation |
| AU765509B2 (en) | 1998-08-28 | 2003-09-18 | Destiny Pharma Limited | Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| EP1155019B1 (de) | 1999-01-25 | 2005-12-07 | National Jewish Medical and Research Center | Substituierte porphyrine und deren therapeutische verwendungen |
| US6403788B1 (en) | 2000-07-11 | 2002-06-11 | Eukarion, Inc. | Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species |
| JP2005508864A (ja) | 2001-06-01 | 2005-04-07 | ナショナル・ジュウィッシュ・メディカル・アンド・リサーチ・センター | 糖尿病の治療、または移植術における使用、または免疫寛容の誘導のためのオキシダントスカベンジャー |
| EP1513537A4 (de) | 2002-06-07 | 2006-09-06 | Univ Duke | Substituierte porphyrine |
| ITFI20020200A1 (it) * | 2002-10-21 | 2004-04-22 | Molteni & C Dei Flii Alitti S P A Societa L | Porfirine meso-sostituite. |
| WO2005042583A1 (en) * | 2003-10-31 | 2005-05-12 | Bio Clue & Solution Co., Ltd. | Ec sod and cell transducing ec sod and use thereof |
| US8318803B2 (en) | 2003-10-31 | 2012-11-27 | Tae-Yoon Kim | EC SOD and use thereof |
| KR20060135922A (ko) * | 2004-03-29 | 2006-12-29 | 이노텍 파마슈티컬스 코포레이션 | 피리딜 치환된 포르피린 화합물 및 이의 사용 방법 |
| JP2009510083A (ja) | 2005-09-28 | 2009-03-12 | イノテック ファーマシューティカルズ コーポレイション | Ｎ−ベンジル置換ピリジルポルフィリン化合物およびその使用方法 |
| WO2008114017A2 (en) * | 2007-03-19 | 2008-09-25 | Imperial Innovations Limited | Compositions and methods relating to influenza infection |
| CA2727803C (en) | 2008-05-13 | 2013-03-12 | University Of Kansas | Metal abstraction peptide (map) tag and associated methods |
| US11382895B2 (en) | 2008-05-23 | 2022-07-12 | National Jewish Health | Methods for treating injury associated with exposure to an alkylating species |
| US9211534B2 (en) | 2011-09-21 | 2015-12-15 | National University Corporation Okayama University | Metalloporphyrin complex, manufacturing process therefor and carbon dioxide fixation catalyst therefrom, as well as process for manufacturing cyclic carbonate |
| CN102584836B (zh) * | 2011-12-31 | 2014-04-16 | 中国科学院化学研究所 | 一种卟啉笼状化合物及其制备方法与应用 |
| WO2013181461A2 (en) | 2012-06-01 | 2013-12-05 | University Of Kansas | Metal abstraction peptide with superoxide dismutase activity |
| US8883857B2 (en) | 2012-12-07 | 2014-11-11 | Baylor College Of Medicine | Small molecule xanthine oxidase inhibitors and methods of use |
| JP6444211B2 (ja) * | 2015-02-24 | 2018-12-26 | 学校法人同志社 | ポルフィリン誘導体、及びこれを含む光増感剤等 |
| CN105399750B (zh) * | 2015-12-11 | 2018-07-17 | 西北师范大学 | 四氮唑卟啉金属配合物及其合成和作为染料敏化剂的应用 |
| CN112694887B (zh) * | 2020-12-07 | 2024-04-26 | 黑龙江省农业科学院植物保护研究所 | 一种发光型传感器及其构筑方法与在检测植物水杨酸含量中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0127797B1 (de) * | 1983-06-03 | 1987-06-16 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Markermoleküle für Fluoreszenz-Immuno-Assays sowie Verfahren und Zwischenprodukte zu deren Herstellung |
| GB8429845D0 (en) * | 1984-11-26 | 1985-01-03 | Efamol Ltd | Porphyrins & cancer treatment |
| US5248603A (en) * | 1985-09-03 | 1993-09-28 | Symbicom Aktiebolag | Superoxide dismutase |
| US4746735A (en) * | 1986-11-21 | 1988-05-24 | The Dow Chemical Company | Regiospecific aryl nitration of meso-substituted tetraarylporphyrins |
| US4892941A (en) * | 1987-04-17 | 1990-01-09 | Dolphin David H | Porphyrins |
| US5051337A (en) * | 1987-06-10 | 1991-09-24 | Director-General Of Agency Of Industrial Science And Technology | Optical recording material |
| GB8805849D0 (en) * | 1988-03-11 | 1988-04-13 | Efamol Holdings | Porphyrins & cancer treatment |
| DE3809671A1 (de) * | 1988-03-18 | 1989-09-28 | Schering Ag | Porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
| FR2632187B1 (fr) * | 1988-06-02 | 1990-09-14 | Centre Nat Rech Scient | Derives de metalloporphyrines, leur preparation, leur application en therapeutique et leur utilisation pour la preparation de molecules hybrides |
| US5171680A (en) * | 1988-06-14 | 1992-12-15 | Chiron Corporation | Superoxide dismutase analogs having novel binding properties |
| DK455789D0 (da) * | 1989-09-15 | 1989-09-15 | Symbicom Ab | Polypeptid |
| US5236915A (en) * | 1990-05-31 | 1993-08-17 | Health Research, Inc. | Meso poly(4-sulfonatophenyl) porphines as MRI image enhancing agents |
| FR2676738B1 (fr) * | 1991-05-22 | 1995-05-05 | Ir2M | Nouveau derive organique de metal de transition a structure porphyrinique, composition therapeutique le contenant, en particulier a activite hypoglycemiante. |
| US5262532A (en) * | 1991-07-22 | 1993-11-16 | E.R. Squibb & Sons, Inc. | Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging |
| US5747026A (en) * | 1993-10-15 | 1998-05-05 | University Of Alabama At Birmingham Research Foundation | Antioxidants |
-
1996
- 1996-06-07 JP JP9502304A patent/JPH11509180A/ja active Pending
- 1996-06-07 WO PCT/US1996/010497 patent/WO1996040223A1/en not_active Ceased
- 1996-06-07 IL IL12245196A patent/IL122451A0/xx unknown
- 1996-06-07 AU AU63870/96A patent/AU725602B2/en not_active Expired
- 1996-06-07 AT AT96923328T patent/ATE306936T1/de active
- 1996-06-07 ES ES96923328T patent/ES2249784T3/es not_active Expired - Lifetime
- 1996-06-07 DE DE69635304T patent/DE69635304T2/de not_active Expired - Lifetime
- 1996-06-07 EP EP96923328A patent/EP0831891B1/de not_active Expired - Lifetime
- 1996-06-07 CA CA2223407A patent/CA2223407C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU725602B2 (en) | 2000-10-12 |
| DE69635304D1 (de) | 2006-03-02 |
| IL122451A0 (en) | 1998-06-15 |
| CA2223407A1 (en) | 1996-12-19 |
| WO1996040223A1 (en) | 1996-12-19 |
| ES2249784T3 (es) | 2006-04-01 |
| CA2223407C (en) | 2011-02-08 |
| DE69635304T2 (de) | 2006-07-20 |
| EP0831891A1 (de) | 1998-04-01 |
| EP0831891A4 (de) | 1999-02-03 |
| AU6387096A (en) | 1996-12-30 |
| JPH11509180A (ja) | 1999-08-17 |
| EP0831891B1 (de) | 2005-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69635304D1 (de) | Faenger fuer oxidantien | |
| ATE238307T1 (de) | Substituierte porphyrinen | |
| ATE291351T1 (de) | Superoxiddismutase memetika | |
| DE69928655D1 (de) | Substituierte porphyrine | |
| MXPA01007451A (es) | Porfirinas sustituidas. | |
| GB9514451D0 (en) | Sustained-release formulation | |
| PL320064A1 (en) | Application of dioxomorpholines for fighting against endoparasites, novel dioxomorphoines and method of obtaining them | |
| NO2015027I2 (no) | Mepolizumab | |
| MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
| HU9700022D0 (en) | Dihydrobenzofuranes | |
| MX9804588A (es) | Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel. | |
| PT865294E (pt) | Processo para a reducao ou a manutencao de niveis reduzidos de lipidos no sangue utilizando composicoes de proteina ob | |
| NZ503308A (en) | Alpha-ketoamide multicatalytic protease inhibitors | |
| ATE510552T1 (de) | Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors | |
| TR199902257T2 (xx) | Tetrahidropirido bile�ikleri | |
| BG102064A (en) | Method for increasing the retinal blood circulation | |
| ATE305517T1 (de) | Neurotrypsin | |
| WO1997008934A3 (en) | Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors | |
| DE59506532D1 (de) | Lutschbonbon mit zahnbelags-neutralisierender wirkung | |
| ZA949564B (en) | Method for treating constipation using dimeticone. | |
| BG103859A (en) | The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions | |
| DE69924385D1 (de) | Verwendung von angiotensin zur behandlung von krebsmetastasierung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0831891 Country of ref document: EP |